��������

After managing a team responsible for the implementation and development of clinical study management at Nantes University Hospital, in 2002, Murielle founded BIOFORTIS, a leading CRO (contract research organization). In addition to achieving the growth of her company, Murielle contributed to local economic development by attracting the MÉRIEUX pharmaceutical group to Nantes. In 2009, BIOFORTIS joined the MÉRIEUX group, and Murielle successfully managed its integration into the MÉRIEUX NUTRISCIENCES subsidiary. In addition, Murielle took on the role of Chair of the “Atlanpole Biothérapies” cluster from 2012 to 2018 with a view to establishing new therapies and accelerating the development of personalized medicine by facilitating joint university and industry research programs.